These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 24052633
1. Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. Wickman L, Afshinnia F, Wang SQ, Yang Y, Wang F, Chowdhury M, Graham D, Hawkins J, Nishizono R, Tanzer M, Wiggins J, Escobar GA, Rovin B, Song P, Gipson D, Kershaw D, Wiggins RC. J Am Soc Nephrol; 2013 Dec; 24(12):2081-95. PubMed ID: 24052633 [Abstract] [Full Text] [Related]
2. Urine podocyte mRNAs mark disease activity in IgA nephropathy. Fukuda A, Sato Y, Iwakiri T, Komatsu H, Kikuchi M, Kitamura K, Wiggins RC, Fujimoto S. Nephrol Dial Transplant; 2015 Jul; 30(7):1140-50. PubMed ID: 25956757 [Abstract] [Full Text] [Related]
3. Urinary podocytes in primary focal segmental glomerulosclerosis. Hara M, Yanagihara T, Kihara I. Nephron; 2001 Nov; 89(3):342-7. PubMed ID: 11598401 [Abstract] [Full Text] [Related]
4. Urine podocyte mRNAs mark progression of renal disease. Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, Venkatareddy M, Chang JW, Wiggins JE, Lienczewski C, Kretzler M, Wiggins RC. J Am Soc Nephrol; 2009 May; 20(5):1041-52. PubMed ID: 19389856 [Abstract] [Full Text] [Related]
5. Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome. Ding F, Wickman L, Wang SQ, Zhang Y, Wang F, Afshinnia F, Hodgin J, Ding J, Wiggins RC. Kidney Int; 2017 Dec; 92(6):1515-1525. PubMed ID: 28754557 [Abstract] [Full Text] [Related]
6. AMPK mediates regulation of glomerular volume and podocyte survival. Banu K, Lin Q, Basgen JM, Planoutene M, Wei C, Reghuvaran AC, Tian X, Shi H, Garzon F, Garzia A, Chun N, Cumpelik A, Santeusanio AD, Zhang W, Das B, Salem F, Li L, Ishibe S, Cantley LG, Kaufman L, Lemley KV, Ni Z, He JC, Murphy B, Menon MC. JCI Insight; 2021 Oct 08; 6(19):. PubMed ID: 34473647 [Abstract] [Full Text] [Related]
7. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies. Eriguchi M, Yotsueda R, Torisu K, Kawai Y, Hasegawa S, Tanaka S, Noguchi H, Masutani K, Kitazono T, Tsuruya K. Am J Physiol Renal Physiol; 2016 Feb 15; 310(4):F322-33. PubMed ID: 26632605 [Abstract] [Full Text] [Related]
8. [The dynamics of the changes in the ultrastructural organization of the podocytes in the primary nephrotic syndrome in children]. Val'kovich EI. Arkh Patol; 1990 Feb 15; 52(2):14-8. PubMed ID: 2353894 [Abstract] [Full Text] [Related]
9. Pediatric nephrotic syndrome: from the simple to the complex. Lane JC, Kaskel FJ. Semin Nephrol; 2009 Jul 15; 29(4):389-98. PubMed ID: 19615560 [Abstract] [Full Text] [Related]
10. Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse. Cara-Fuentes G, Venkatareddy M, Verma R, Segarra A, Cleuren AC, Martínez-Ramos A, Johnson RJ, Garg P. Pediatr Nephrol; 2020 Oct 15; 35(10):1887-1896. PubMed ID: 32399663 [Abstract] [Full Text] [Related]
11. The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H. Am J Nephrol; 2000 Oct 15; 20(3):175-9. PubMed ID: 10878397 [Abstract] [Full Text] [Related]
12. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis. Samejima K, Nakatani K, Suzuki D, Asai O, Sakan H, Yoshimoto S, Yamaguchi Y, Matsui M, Akai Y, Toyoda M, Iwano M, Saito Y. Nephron Clin Pract; 2012 Oct 15; 120(1):c1-7. PubMed ID: 22126861 [Abstract] [Full Text] [Related]
13. Urinary and glomerular podocytes in patients with chronic kidney diseases. Hanamura K, Tojo A, Fujita T. Clin Exp Nephrol; 2014 Feb 15; 18(1):95-103. PubMed ID: 23670304 [Abstract] [Full Text] [Related]
14. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury. Hara M, Yanagihara T, Kihara I, Higashi K, Fujimoto K, Kajita T. J Am Soc Nephrol; 2005 Feb 15; 16(2):408-16. PubMed ID: 15625073 [Abstract] [Full Text] [Related]
15. Podocyte mRNA in the urinary sediment of minimal change nephropathy and focal segmental glomerulosclerosis. Szeto CC, Wang G, Chow KM, Lai FM, Ma TK, Kwan BC, Luk CC, Li PK. Clin Nephrol; 2015 Oct 15; 84(4):198-205. PubMed ID: 26308082 [Abstract] [Full Text] [Related]
16. Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker. Fukuda A, Wickman LT, Venkatareddy MP, Wang SQ, Chowdhury MA, Wiggins JE, Shedden KA, Wiggins RC. Nephrol Dial Transplant; 2012 Nov 15; 27(11):4079-87. PubMed ID: 22863839 [Abstract] [Full Text] [Related]
17. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. Gödel M, Hartleben B, Herbach N, Liu S, Zschiedrich S, Lu S, Debreczeni-Mór A, Lindenmeyer MT, Rastaldi MP, Hartleben G, Wiech T, Fornoni A, Nelson RG, Kretzler M, Wanke R, Pavenstädt H, Kerjaschki D, Cohen CD, Hall MN, Rüegg MA, Inoki K, Walz G, Huber TB. J Clin Invest; 2011 Jun 15; 121(6):2197-209. PubMed ID: 21606591 [Abstract] [Full Text] [Related]
18. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome. Wagrowska-Danilewicz M, Stasikowska O, Danilewicz M. Pol J Pathol; 2006 Jun 15; 57(1):17-21. PubMed ID: 16739878 [Abstract] [Full Text] [Related]
19. Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy. Fujino T, Hasebe N. BMC Nephrol; 2016 Nov 17; 17(1):179. PubMed ID: 27855638 [Abstract] [Full Text] [Related]
20. [Evaluation of the podocytes in urine in the nephrotic syndrome in childhood]. Spadło A, Wyka K, Kowalewska-Pietrzak M, Bodalski J. Pol Merkur Lekarski; 2007 Apr 17; 22(130):254-7. PubMed ID: 17684921 [Abstract] [Full Text] [Related] Page: [Next] [New Search]